AVONEX
Biological
Biogen, Inc.
Total Payments
$1.9M
Transactions
10,569
Doctors
2,899
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $111,757 | 1,735 | 640 |
| 2023 | $336,601 | 1,500 | 753 |
| 2022 | $279,288 | 2,099 | 875 |
| 2021 | $299,906 | 2,335 | 1,186 |
| 2020 | $162,093 | 1,048 | 673 |
| 2019 | $53,738 | 762 | 389 |
| 2018 | $342,042 | 863 | 141 |
| 2017 | $306,452 | 227 | 22 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $864,543 | 158 | 45.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $480,124 | 45 | 25.4% |
| Unspecified | $337,646 | 8 | 17.8% |
| Food and Beverage | $165,549 | 9,570 | 8.8% |
| Travel and Lodging | $41,649 | 667 | 2.2% |
| Education | $2,365 | 121 | 0.1% |
Payments by Type
General
$1.6M
10,561 transactions
Research
$337,646
8 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluating the effect of Avonex and Plegridy on efficacy measures in pediatric patients from USNPMSC registry | Biogen, Inc. | $120,750 | 0 |
| Recovery from first relapse as a prognostic factor for disability progression in the long-term: a post-hoc analysis of the CHAMPS-CHAMPIONS dataset | Biogen, Inc. | $100,715 | 0 |
| GLB-AVX-19-11478 | Biogen, Inc. | $79,995 | 0 |
| Longitudinal Assessment of Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis on Avonex | Biogen, Inc. | $28,609 | 0 |
| SRA for Avonex Progression Research with NYSMSC - Vaughn Avonex Manuscript (Inuzuka) | Biogen, Inc. | $7,576 | 0 |
Top Doctors Receiving Payments for AVONEX — Page 116
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MSN,NP-C | Family | Gilbert, AZ | $4.95 | 1 |
| , D.O | Neurology | St George, UT | $4.71 | 1 |
| , M.D | Neurology | Roseburg, OR | $4.67 | 1 |
| , MD | Neurology | Great Falls, MT | $4.35 | 1 |
| , MD | Neurology | Richmond, VA | $4.19 | 1 |
| , MD | Neurology | Tulsa, OK | $3.93 | 1 |
| , CRNP | Gerontology | Great Falls, MT | $3.81 | 1 |
| , D.O | Student in an Organized Health Care Education/Training Program | Albany, NY | $3.59 | 1 |
| , MD | Neurology | Bad Axe, MI | $3.36 | 2 |
| , PA | Physician Assistant | Overland Park, KS | $3.35 | 1 |
| , MD | Neurology | Fort Smith, AR | $3.14 | 1 |
| , MD | Neurology | Newport News, VA | $2.93 | 1 |
| , DO | Neurology | Kansas City, MO | $2.48 | 2 |
| , M.D | Neurology | Frisco, TX | $2.37 | 1 |
| , M.D | Neurology | New Hyde Park, NY | $2.05 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | New Hyde Park, NY | $2.05 | 1 |
| , MD | Neurology | Buffalo, NY | $1.91 | 1 |
| , M.D | Neurology | Kansas City, MO | $1.63 | 1 |
| , MD | Specialist | Hackensack, NJ | $1.46 | 1 |
| , M.D | Specialist | Hackensack, NJ | $1.46 | 1 |
| , MD | Specialist | Hackensack, NJ | $1.46 | 1 |
| , MD | Specialist | Hackensack, NJ | $1.46 | 1 |
| , MD | Specialist | Hackensack, NJ | $1.46 | 1 |
| , MD | Neurology | Kansas City, MO | $0.85 | 1 |
| Michael Ryan | — | Merriam, KS | $0.36 | 1 |
Ad
Manufacturing Companies
- Biogen, Inc. $1.9M
Product Information
- Type Biological
- Total Payments $1.9M
- Total Doctors 2,899
- Transactions 10,569
About AVONEX
AVONEX is a biological associated with $1.9M in payments to 2,899 healthcare providers, recorded across 10,569 transactions in the CMS Open Payments database. The primary manufacturer is Biogen, Inc..
Payment data is available from 2017 to 2024. In 2024, $111,757 was paid across 1,735 transactions to 640 doctors.
The most common payment nature for AVONEX is "Consulting Fee" ($864,543, 45.7% of total).
AVONEX is associated with 5 research studies, including "Evaluating the effect of Avonex and Plegridy on efficacy measures in pediatric patients from USNPMSC registry" ($120,750).